Why the study?
The feasibility and safety of a completely implantable system for long-term ambulatory monitoring of important haemodynamic parameters in patients with severe cardiopulmonary disease required evaluation.
Is a completely implantable system for long-term ambulatory haemodynamic monitoring feasible and safe in patients with severe cardiopulmonary disease?
Is a completely implantable system for long-term ambulatory haemodynamic monitoring feasible and safe in patients with severe cardiopulmonary disease?
A completely implantable system for long-term ambulatory haemodynamic monitoring is feasible and provides excellent data quality in patients with severe cardiopulmonary disease.
Answers are grounded in this paper and cite their sources.
Supports feasibility in severe cardiopulmonary disease; hypothesis-generating and should not yet change practice.
AIMS: This study evaluates the feasibility and safety of a completely implantable system for long-term ambulatory monitoring of important haemodynamic parameters in patients with severe cardiopulmonary disease. METHODS: The design of the implantable monitoring system is similar to a conventional single lead pacemaker. A lead with incorporated biosensors for the continuous recording of pressure and oxygen saturation signals is positioned in the right ventricle and connected to a monitor and memory device subcutaneously implanted like an ordinary pacemaker can. RESULTS: Five patients with implanted haemodynamic monitoring systems have been followed for from 7 to 16 months. Continuous measurements of activity, heart rate, mixed venous oxygen saturation and estimated pulmonary artery diastolic pressure were registered with variable resolution during daily living and predefined provocations. The memory covered a maximum of 3 weeks at low resolution. The monitored parameters showed an adequate and significant response to various haemodynamic situations. Except for the demand of recalibration of two oxygen sensors, there were no technical problems and the quality of data were excellent. CONCLUSION: Long-term ambulatory haemodynamic monitoring is feasible and potentially useful for the management of patients with severe cardiopulmonary disease.
No takes yet. Share an insight, caveat, or question.
Annika Ohlsson (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: